| 臺大學術典藏 |
2021-07-06T02:37:29Z |
The Association Between the Use of Cholinesterase Inhibitors and Cardiovascular Events Among Older Patients With Alzheimer Disease
|
Hsiao S.-H.; Hwang T.-J.; FANG-JU LIN; Sheu J.-J.; Wu C.-H. |
| 臺大學術典藏 |
2021-07-06T02:37:29Z |
Nephrotoxicity of teicoplanin-based combination therapy: Focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams
|
Tai C.-H.; Shao C.-H.; Wang C.-C.; FANG-JU LIN; Wang J.-T.; Wu C.-C. |
| 臺大學術典藏 |
2021-07-06T02:37:28Z |
Risk of Intracranial Hemorrhage With Concomitant Use of Antidepressants and Nonsteroidal Anti-inflammatory Drugs: A Nested Case-Control Study
|
Hou P.-C.; FANG-JU LIN; Lin S.-Y.; Hwang T.-J.; Wang C.-C. |
| 臺大學術典藏 |
2021-03-14T23:24:36Z |
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation and valvular heart disease
|
Li, Hsing Jung; SHIN YI LIN; FANG-JU LIN; Hung, Chi Sheng; CHI-CHUAN WANG |
| 臺大學術典藏 |
2021-03-14T23:24:27Z |
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
|
Shao, Chi Hao; Tai, Chih Hsun; FANG-JU LIN; Wu, Chien Chih; JANN-TAY WANG; CHI-CHUAN WANG |
| 臺大學術典藏 |
2020-12-17T02:40:29Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.;Kao H.-L.;Wang C.-C.;Lin S.-Y.;Fang-Ju Lin; Wang Y.-H.; Kao H.-L.; Wang C.-C.; Lin S.-Y.; FANG-JU LIN |
| 臺大學術典藏 |
2020-12-17T02:40:28Z |
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan
|
Huang K.;Fang-Ju Lin;Ou H.-T.;Hsu C.-N.;Huang L.-Y.;Wang C.-C.;Toh S.; Huang K.; FANG-JU LIN; Ou H.-T.; Hsu C.-N.; Huang L.-Y.; Wang C.-C.; Toh S. |
| 臺大學術典藏 |
2020-12-17T02:40:26Z |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan
|
Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I.; FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W. |
| 臺大學術典藏 |
2020-12-17T02:40:23Z |
Response
|
Fang-Ju Lin;Chang T.-Y.;Chien J.-Y.; FANG-JU LIN; Chang T.-Y.; Chien J.-Y. |
| 臺大學術典藏 |
2020-12-17T02:40:20Z |
Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
|
FANG-JU LIN; Chou C.; Cheng C.-N.;Wang C.-Y.;Lin H.-W.;Chang T.-Y.;Lin H.-J.;Chou C.;Fang-Ju Lin; Cheng C.-N.; Wang C.-Y.; Lin H.-W.; Chang T.-Y.; Lin H.-J. |
| 臺大學術典藏 |
2020-12-17T02:37:03Z |
Nationwide trends in incidence, healthcare utilization, and mortality in hospitalized heart failure patients in Taiwan
|
Wang T.-D.; Huang S.-T.; Wang C.-Y.; FANG-JU LIN; Chen H.-M.; Hsiao F.-Y. |
| 臺大學術典藏 |
2020-12-17T02:37:03Z |
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan
|
Huang K.; FANG-JU LIN; Ou H.-T.; Hsu C.-N.; Huang L.-Y.; Wang C.-C.; Toh S. |
| 臺大學術典藏 |
2020-12-17T02:37:02Z |
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea
|
Hsiao F.-Y.; Shih Y.-R.; Liao K.-H.; Chen Y.-H.; FANG-JU LIN |
| 臺大學術典藏 |
2020-12-17T02:37:02Z |
Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD
|
Chang T.-Y.; Chien J.-Y.; Wu C.-H.; Dong Y.-H.; FANG-JU LIN |
| 臺大學術典藏 |
2020-12-17T02:37:01Z |
Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
|
Cheng C.-N.; Wang C.-Y.; Lin H.-W.; Chang T.-Y.; Lin H.-J.; Chou C.; FANG-JU LIN |
| 臺大學術典藏 |
2020-12-17T02:19:46Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.; Kao H.-L.; Wang C.-C.; Lin S.-Y.; FANG-JU LIN |
| 臺大學術典藏 |
2020-12-17T02:19:45Z |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
|
FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W.; Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I. |
| 臺大學術典藏 |
2020-12-17T02:19:45Z |
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan
|
Huang K.; FANG-JU LIN; Ou H.-T.; Hsu C.-N.; Huang L.-Y.; Wang C.-C.; Toh S. |
| 臺大學術典藏 |
2020-12-17T02:19:45Z |
Nationwide trends in incidence, healthcare utilization, and mortality in hospitalized heart failure patients in Taiwan
|
Wang T.-D.; Huang S.-T.; Wang C.-Y.; FANG-JU LIN; Chen H.-M.; Hsiao F.-Y. |
| 臺大學術典藏 |
2020-12-17T02:19:44Z |
Response
|
FANG-JU LIN; Chang T.-Y.; Chien J.-Y. |
| 臺大學術典藏 |
2020-12-17T02:19:44Z |
Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD
|
Chang T.-Y.; Chien J.-Y.; Wu C.-H.; Dong Y.-H.; FANG-JU LIN |
| 臺大學術典藏 |
2020-12-17T02:19:43Z |
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea
|
Shih Y.-R.; Liao K.-H.; Chen Y.-H.; FANG-JU LIN; Hsiao F.-Y. |
| 臺大學術典藏 |
2020-12-17T02:19:42Z |
Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
|
Cheng C.-N.; Wang C.-Y.; Lin H.-W.; Chang T.-Y.; Lin H.-J.; Chou C.; FANG-JU LIN |
| 臺大學術典藏 |
2020-02-25T09:46:29Z |
Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel
|
CJ Langer; V Hirsh; I Okamoto; FANG-JU LIN; Y Wan; S Whiting; T J Ong; MF Renschler; MF Botteman |
| 臺大學術典藏 |
2020-02-25T09:43:24Z |
A Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non–Vitamin K Antagonist Oral Anticoagulants and Warfarin
|
Fong-Ci Lin;Shih-Tsung Huang;Rung Ji Shang;Chi-Chuan Wang;Fei-Yuan Hsiao;Fang-Ju Lin;Mei-Shu Lin;Kuan-Yu Hung;Jui Wang;Li-Jiuan Shen;Feipei Lai;Chih-Fen Huang; Fong-Ci Lin; Shih-Tsung Huang; Rung Ji Shang; Chi-Chuan Wang; Fei-Yuan Hsiao; FANG-JU LIN; Mei-Shu Lin; Kuan-Yu Hung; Jui Wang; Li-Jiuan Shen; Feipei Lai; Chih-Fen Huang |
